Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Thomas Broggini

    TitlePostdoctoral Scholar
    SchoolUniversity of California, San Diego
    DepartmentPhysics
    Address9500 Gilman Drive #0374
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Bayerl SH, Nieminen-Kelhä M, Broggini T, Vajkoczy P, Prinz V. Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice. J Vis Exp. 2016 Dec 29; (118). PMID: 28060307.
        View in: PubMed
      2. Broggini T, Schnell L, Ghoochani A, Mateos JM, Buchfelder M, Wiendieck K, Schäfer MK, Eyupoglu IY, Savaskan NE. Plasticity Related Gene 3 (PRG3) overcomes myelin-associated growth inhibition and promotes functional recovery after spinal cord injury. Aging (Albany NY). 2016 Oct 15. PMID: 27744421.
        View in: PubMed
      3. Broggini T, Piffko A, Hoffmann CJ, Harms C, Vajkoczy P, Czabanka M. Passive Entrapment of Tumor Cells Determines Metastatic Dissemination to Spinal Bone and Other Osseous Tissues. PLoS One. 2016; 11(9):e0162540. PMID: 27603673.
        View in: PubMed
      4. Fan Z, Bittermann-Rummel P, Yakubov E, Chen D, Broggini T, Sehm T, Hatipoglu Majernik G, Hock SW, Schwarz M, Engelhorn T, Doerfler A, Buchfelder M, Eyupoglu IY, Savaskan NE. PRG3 induces Ras-dependent oncogenic cooperation in gliomas. Oncotarget. 2016 May 3; 7(18):26692-708. PMID: 27058420.
        View in: PubMed
      5. Broggini T, Wüstner M, Harms C, Stange L, Blaes J, Thomé C, Harms U, Mueller S, Weiler M, Wick W, Vajkoczy P, Czabanka M. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment. Cancer Lett. 2016 Oct 1; 380(2):568-76. PMID: 26297987.
        View in: PubMed
      6. Broggini T, Czabanka M, Piffko A, Harms C, Hoffmann C, Mrowka R, Wenke F, Deutsch U, Grötzinger C, Vajkoczy P. ICAM1 depletion reduces spinal metastasis formation in vivo and improves neurological outcome. Eur Spine J. 2015 Oct; 24(10):2173-81. PMID: 25711910.
        View in: PubMed
      7. Savaskan NE, Fan Z, Broggini T, Buchfelder M, Eyupoglu IY. Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight. Curr Neuropharmacol. 2015; 13(2):258-65. PMID: 26411769.
        View in: PubMed
      8. Czabanka M, Bruenner J, Parmaksiz G, Broggini T, Topalovic M, Bayerl SH, Auf G, Kremenetskaia I, Nieminen M, Jabouille A, Mueller S, Harms U, Harms C, Koch A, Heppner FL, Vajkoczy P. Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas. Eur J Cancer. 2013 Jun; 49(9):2243-52. PMID: 23499430.
        View in: PubMed
      9. Broggini T, Nitsch R, Savaskan NE. Plasticity-related gene 5 (PRG5) induces filopodia and neurite growth and impedes lysophosphatidic acid- and nogo-A-mediated axonal retraction. Mol Biol Cell. 2010 Feb 15; 21(4):521-37. PMID: 20032306; PMCID: PMC2820418.